All news

ProShare Advisors LLC Sells 2,206 Shares of Regeneron Pharmaceuticals, Inc. $REGN

Alpha Vantage · MarketBeat · · AI-summarised by FinFlash

ProShare Advisors LLC decreased its stake in Regeneron Pharmaceuticals (NASDAQ:REGN) by 1.9% during the third quarter, selling 2,206 shares while retaining 117,034 shares valued at $88.7 million. The biopharmaceutical company reported strong third-quarter results, exceeding analyst expectations with revenue up 36.3% year-over-year to $5.12 billion and non-GAAP EPS of $20.07.

Read original source

REGN company analysis

Understand the context

Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.